Alnylam Pharmaceuticals (DE:DUL)
FRANKFURT:DUL
Holding DE:DUL?
Track your performance easily

Alnylam Pharma (DUL) Cash flow

1 Followers

Alnylam Pharma Cash Flow

DE:DUL's free cash flow for Q3 2024 was $39.52M. For the 2024 fiscal year, DE:DUL's free cash flow was decreased by $655.28M and operating cash flow was $43.71M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ 56.55M$ 104.16M$ -541.27M$ -641.69M$ -614.96M$ -308.60M
Investing Cash Flow
$ -304.59M$ -336.35M$ 169.35M$ -273.30M$ -435.52M$ -387.51M
Financing Cash Flow
$ 302.39M$ 172.13M$ 425.75M$ 1.25B$ 994.98M$ 823.18M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 3.57B$ 814.88M$ 868.56M$ 499.05M$ 499.05M$ 549.63M
Income Tax Paid Supplemental Data
-----$ 2.57M
Interest Paid Supplemental Data
$ 60.69M$ 32.12M$ 45.23M$ 24.66M-$ 172.00K
Issuance Of Capital Stock
----$ 99.50M$ 781.90M
Issuance Of Debt
--$ 254.00M$ 500.00M$ 200.00M$ -30.00M
Repayment Of Debt
--$ -762.11M--$ -30.00M
Free Cash Flow
$ 16.06M$ 41.95M$ -613.33M$ -718.07M$ -685.32M$ -448.75M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Alnylam Pharma Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis